Sterile Product Manufacture
Questions 1. Sterile product manufacture covers:
A. Only finished dosage forms
B. Only active substances
C. A wide range of product types including active substances, excipients, packaging, and finished forms
D. Only biotechnology products
Answer: C
Questions 2. Sterile products may be produced in:
A. Only manual processes
B. Only fully automated systems
C. Both automated and manual processes
D. Only closed systems
Answer: C
Questions 3. The Annex provides guidance for:
A. Facility design only
B. Equipment design only
C. Facilities, equipment, systems, and procedures
D. Personnel training only
Answer: C
Questions 4. The main objective of the Annex is to prevent:
A. Marketing delays
B. Product discoloration
C. Microbial, particulate, and endotoxin/pyrogen contamination
D. Packaging errors
Answer: C
Questions 5. QRM applies to:
A. Only selected paragraphs
B. Only equipment sections
C. The entire document
D. Only personnel controls
Answer: C
Questions 6. Specified limits or frequencies in the Annex represent:
A. Optional guidelines
B. Industry preferences
C. Minimum requirements
D. Theoretical suggestions
Answer: C
Questions 7. These limits exist because of:
A. Cost-saving initiatives
B. Historical regulatory experience
C. Manufacturer preference
D. International politics
Answer: B
Use of Principles for Non-Sterile Products
Questions 8. Some guidance in the Annex may be applied to non-sterile products when:
A. Microbial control is irrelevant
B. Only visual quality is needed
C. Control of contamination is important
D. They are packaged in glass containers
Answer: C
Questions 9. Manufacturers applying Annex guidance to non-sterile products must:
A. Report to regulators weekly
B. Clearly document which principles are used
C. Seek special certification
D. Redesign their entire facility
Answer: B
Pharmaceutical Quality System (PQS)
Principle – Key Requirements
Questions 10. Sterile manufacturing has special requirements to minimize:
A. Product weight variation
B. Microbial, particulate, and pyrogen contamination
C. Operator travel time
D. Marketing failures
Answer: B
Questions 11. Facility, equipment, and processes must be:
A. Unregulated
B. Designed, qualified, and/or validated
C. Used without documentation
D. Operated only manually
Answer: B
Questions 12. Technologies such as RABS and isolators:
A. Increase risk to sterile product
B. Have no role in sterile manufacturing
C. Increase product protection from contamination
D. Reduce automation
Answer: C
Questions 13. Technologies may assist in:
A. Eliminating the need for monitoring
B. Rapid detection of contaminants
C. Replacing personnel entirely
D. Cooling the room
Answer: B
Questions 14. Personnel should have:
A. Only general education
B. Minimal training
C. Adequate qualifications, experience, and training
D. No microbiological knowledge
Answer: C
Questions 15. Personnel training should emphasize:
A. Laboratory management
B. Cost tracking
C. Protection of sterile product
D. Office procedures
Answer: C
Questions 16. Monitoring systems for sterile products should be:
A. Ignored after implementation
B. Used without qualification
C. Designed, commissioned, qualified, and reviewed
D. Designed only by engineering contractors
Answer: C
Questions 17. Raw and packaging materials should be tested for:
A. Taste
B. Weight uniformity
C. Bioburden and endotoxin/pyrogen levels
D. Color intensity
Answer: C
Principle QRM Application
Questions 18. Processes and equipment should be managed according to:
A. GDP principles
B. QRM principles
C. Local hygiene rules only
D. Staff convenience
Answer: B
Questions 19. Alternative approaches must include:
A. Marketing input
B. Rationale, risk assessment, and mitigation
C. Cost-benefit approval
D. External legal review
Answer: B
Questions 20. QRM priorities begin with:
A. Monitoring
B. Investigations
C. Appropriate facility, equipment, and process design
D. Operator work schedules
Answer: C
Questions 21. Monitoring alone:
A. Ensures sterility
B. Is faster than designing processes
C. Does not assure sterility
D. Replaces validation
Answer: C
Principle Contamination Control Strategy (CCS)
Questions 22. The CCS should:
A. Focus only on documentation
B. Define critical control points
C. Replace GMP requirements
D. Ignore procedural controls
Answer: B
Questions 23. The CCS should assess:
A. Only design controls
B. Only procedural controls
C. All design, technical, organizational, and monitoring controls
D. Only equipment maintenance
Answer: C
Questions 24. The CCS should be:
A. Static after initial approval
B. Actively reviewed and updated
C. Reviewed only during a regulatory inspection
D. Optional
Answer: B
Questions 25. Existing systems:
A. Must always be replaced
B. Should be referenced in the CCS
C. Cannot be part of the CCS
D. Must be outsourced
Answer: B
Questions 26. The CCS supports:
A. Continual improvement
B. Reduced quality oversight
C. Eliminating monitoring
D. Less documentation
Answer: A
Principle Interrelated Contamination Measures
Questions 27. Contamination control involves:
A. Isolated, unrelated steps
B. A series of interrelated events and measures
C. Only visual inspection
D. Only chemical analysis
Answer: B
Questions 28. Effectiveness of contamination measures should be considered:
A. Individually only
B. Collectively
C. Only after failures occur
D. Only during audits
Answer: B
Principle Elements of a CCS
Questions 29. Potential contamination sources include:
A. Only personnel
B. Only equipment
C. Microbial, cellular debris, and particulate matter
D. Only pyrogens
Answer: C
Questions 30. CCS elements include:
A. Marketing strategies
B. Plant and process design
C. Sales forecasting
D. Distribution logistics
Answer: B
Questions 31. Personnel must be considered in the CCS because:
A. They design buildings
B. They may introduce contamination
C. They determine product pricing
D. They work remotely
Answer: B
Questions 32. Utilities are included because they can:
A. Determine product labeling
B. Affect contamination levels
C. Identify customers
D. Manage documentation
Answer: B
Questions 33. Vendor approval is required for:
A. All suppliers without exception
B. Key component suppliers and critical service providers
C. Marketing contractors
D. Human resources services
Answer: B
Questions 34. Outsourced activities require:
A. No oversight
B. Reassignment to internal teams
C. Management and sharing of critical information
D. Only verbal agreements
Answer: C
Questions 35. Process risk management helps:
A. Minimize compliance documentation
B. Control quality-related risks
C. Increase product shelf-life
D. Replace monitoring
Answer: B
Questions 36. Validation of sterilisation processes is:
A. Optional
B. A CCS element
C. Unrelated to contamination
D. Only for non-sterile products
Answer: B
Questions 37. Preventative maintenance should ensure:
A. Lower staff workload
B. No increased contamination risks
C. No need for cleaning
D. Only mechanical reliability
Answer: B
Questions 38. Cleaning and disinfection are:
A. Irrelevant to CCS
B. Required CCS elements
C. Optional for closed systems
D. Replaced by automation
Answer: B
Questions 39. Monitoring systems should consider:
A. Outdated manual methods only
B. The feasibility of introduction of alternative scientifically sound methods
C. Only operator preferences
D. Cost-saving methods only
Answer: B
Questions 40. Prevention mechanisms include:
A. Trend analysis and CAPA
B. Marketing analysis
C. Sales forecasting
D. Public relations
Answer: A
Questions 41. Continuous improvement is based on:
A. Regulatory penalties
B. Information derived from CCS elements
C. Operator opinions
D. Annual sales reports
Answer: B
Questions 42. CCS reviews should lead to:
A. Elimination of documentation
B. Updates within the PQS where appropriate
C. Removal of monitoring systems
D. Increase in production speed
Answer: B
Questions 43. Changes to systems must be assessed for:
A. Financial impact only
B. Impact on CCS
C. Marketing strategy
D. Operator preference
Answer: B
Principle Assuring Sterility
Questions 44. Manufacturers must take:
A. Only minimal steps
B. All necessary steps to ensure sterility
C. Only administrative steps
D. No steps beyond final testing
Answer: B
Questions 45. Sole reliance for sterility should NOT be placed on:
A. In-process controls
B. Facility design
C. Finished product testing
D. Personnel qualification
Answer: C
Questions 46. One of the primary benefits of advanced technologies (e.g., RABS, isolators) is:
A. Reducing need for skilled personnel
B. Enhancing protection from contamination sources
C. Eliminating validation activities
D. Reducing equipment cost
Answer: B
Questions 47. Monitoring systems confirm:
A. That product is sterile by themselves
B. That design and procedures are correctly implemented
C. That operators follow break schedules
D. That warehouses are organized
Answer: B
Questions 48. The CCS defines:
A. The cost per batch
B. Critical control points
C. Employee roles
D. Supplier contracts
Answer: B
Questions 49. Raw materials must be controlled to ensure:
A. Acceptable taste
B. Appropriate bioburden levels
C. Customer satisfaction
D. Long shelf-life
Answer: B
Questions 50. Elements such as utilities and closures are considered because they:
A. Affect product pricing
B. Can introduce contamination
C. Are regulated by finance
D. Do not impact quality
Answer: B
Questions 51. Management of outsourced activities includes:
A. Reducing quality expectations
B. Ensuring transfer of critical information
C. Avoiding audits
D. Delegating all responsibility
Answer: B
Questions 52. Trend analysis supports:
A. Prevention mechanisms
B. Marketing decisions
C. Financial forecasting
D. Staff scheduling
Answer: A
Questions 53. Unplanned maintenance should be:
A. Ignored
B. Conducted without documentation
C. Managed to avoid contamination risks
D. Outsourced automatically
Answer: C
Questions 54. The CCS requires:
A. Limited technical knowledge
B. Detailed technical and process knowledge
C. Only financial review
D. Only visual inspections
Answer: B
Questions 55. Cellular debris contamination refers to:
A. Packaging waste
B. Pyrogen and endotoxin
C. Cleaning residue
D. Filter fibers only
Answer: B
Questions 56. Collective evaluation of contamination controls ensures:
A. Improved marketing position
B. Overall contamination prevention effectiveness
C. Lower manufacturing costs
D. Faster production
Answer: B
Questions 57. Monitoring systems should be:
A. Avoided to save costs
B. Designed with potential adoption of alternative methods
C. Based only on traditional methods
D. Eliminated in automated facilities
Answer: B
Questions 58. CCS effectiveness should be reviewed during:
A. Management review
B. Customer complaints only
C. Sales meetings
D. Staff recruitment
Answer: A
Questions 59. The strategy outlined in the CCS must ensure:
A. Higher batch size
B. Robust assurance of contamination prevention
C. More rapid product distribution
D. Reduced operator training
Answer: B
Questions 60. Sterility assurance relies on:
A. Design, controls, procedures, and contamination prevention—not final tests alone
B. Finished product testing alone
C. Operator visual inspection
D. Packaging appearance
Answer: A